-
The Role of Cytochromes P450 and Aldo-Keto Reductases in Prognosis of Breast Carcinoma Patients
Viktor Hlaváč, Veronika Brynychová, Radka Václavíková, Marie Ehrlichová, David Vrána, Václav Pecha, Markéta Trnková, Roman
Kodet, Marcela Mrhalová, Kateřina Kubáčková, Jiří Gatěk, Petr Vážan, and Pavel Souček
Medicine
(2014)
93 :e255
-
Differential dependency network analysis to identify condition-specific topological changes in biological networks
Bai Zhang, Huai Li, Rebecca B. Riggins, Ming Zhan, Jianhua Xuan, Zhen Zhang, Eric P. Hoffman, Robert Clarke, and Yue Wang
Bioinformatics
(2009)
25 :526
-
A Study on Genetic Variants of Fibroblast Growth Factor Receptor 2 (FGFR2) and the Risk of Breast Cancer from North India
Sarah Siddiqui, Shilpi Chattopadhyay, Md. Salman Akhtar, Mohammad Zeeshan Najm, S. V. S. Deo, N. K. Shukla, Syed Akhtar Husain,
and Nancy Lan Guo
PLoS ONE
(2014)
9 :e110426
-
Cellular Mechanisms of Zinc Dysregulation: A Perspective on Zinc Homeostasis as an Etiological Factor in the Development and
Progression of Breast Cancer
Samina Alam and Shannon L. Kelleher
Nutrients
(2012)
4 :875
-
A Novel Color Change Mechanism for Breast Cancer Biomarker Detection: Naphthoquinones as Specific Ligands of Human Arylamine
N-Acetyltransferase 1
Nicola Laurieri, James E. Egleton, Amy Varney, Cyrille C. Thinnes, Camilo E. Quevedo, Peter T. Seden, Sam Thompson, Fernando
Rodrigues-Lima, Julien Dairou, Jean-Marie Dupret, Angela J. Russell, Edith Sim, and Syed A. Aziz
PLoS ONE
(2013)
8 :e70600
-
How different are luminal A and basal breast cancers?
François Bertucci, Pascal Finetti, Nathalie Cervera, Emmanuelle Charafe-Jauffret, Max Buttarelli, Jocelyne Jacquemier, Max
Chaffanet, Dominique Maraninchi, Patrice Viens, and Daniel Birnbaum
International Journal of Cancer
(2009)
124 :1338
-
Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy
in breast cancer: Experience of the REMAGUS 02 phase II trial
F. Valet, P. de Cremoux, F. Spyratos, N. Servant, M.E. Dujaric, D. Gentien, J. Lehmann-Che, V. Scott, B. Sigal-Zafrani, M.C.
Mathieu, P. Bertheau, J.M. Guinebretière, J.Y. Pierga, S. Delaloge, S. Giacchetti, E. Brain, O. Tembo, M. Marty, and B. Asselain
The Breast
(2013)
22 :1052
-
miR-1290 and its potential targets are associated with characteristics of estrogen receptor -positive breast cancer
Y. Endo, T. Toyama, S. Takahashi, N. Yoshimoto, M. Iwasa, T. Asano, Y. Fujii, and H. Yamashita
Endocrine Related Cancer
(2013)
20 :91
-
RET in breast cancer: functional and therapeutic implications
Andrea Morandi, Ivan Plaza-Menacho, and Clare M. Isacke
Trends in Molecular Medicine
(2011)
17 :149
-
A mechanism for epithelial–mesenchymal transition and anoikis resistance in breast cancer triggered by zinc channel ZIP6 and
STAT3 (signal transducer and activator of transcription 3)
Christer Hogstrand, Peter Kille, Margaret Leigh Ackland, Stephen Hiscox, and Kathryn M. Taylor
Biochemical Journal
(2013)
455 :229
-
Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes
Gabriela C. Fernandes, Rodrigo A. D. Michelli, Cristovam Scapulatempo-Neto, and Edenir I. Palmero
Hereditary Cancer in Clinical Practice
(2016)
14 :
-
Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and
implies interactions with ErbB family
Sandeep Sanga, Bradley M Broom, Vittorio Cristini, and Mary E Edgerton
BMC Medical Genomics
(2009)
2 :
-
Endoplasmic reticulum stress, the unfolded protein response, and gene network modeling in antiestrogen resistant breast cancer
Robert Clarke, Ayesha N. Shajahan, Yue Wang, John J. Tyson, Rebecca B. Riggins, Louis M. Weiner, William T. Bauman, Jianhua
Xuan, Bai Zhang, Caroline Facey, Harini Aiyer, Katherine Cook, F. Edward Hickman, Iman Tavassoly, Anael Verdugo, Chun Chen,
Alan Zwart, Anni Wärri, and Leena A. Hilakivi-Clarke
Hormone Molecular Biology and Clinical Investigation
(2011)
5 :
-
Comparative evaluation of ERα and ERβ significance in breast cancer: state of the art
Etienne Leygue and Leigh Murphy
Expert Review of Endocrinology & Metabolism
(2011)
6 :333
-
Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer
YIQING QU, YIE YANG, DEDONG MA, and WEI XIAO
Oncology Reports
(2012)
27 :1277
-
FGFR2 Abnormalities Underlie a Spectrum of Bone, Skin, and Cancer Pathologies
Masaru Katoh
Journal of Investigative Dermatology
(2009)
129 :1861
-
Methylated polycyclic aromatic hydrocarbons and/or their metabolites are important contributors to the overall estrogenic
activity of polycyclic aromatic hydrocarbon-contaminated soils
Monika M. Lam, Magnus Engwall, Michael S. Denison, and Maria Larsson
Environmental Toxicology and Chemistry
(2018)
37 :385
-
Genetic Ablation of Caveolin-1 Drives Estrogen-Hypersensitivity and the Development of DCIS-Like Mammary Lesions
Isabelle Mercier, Mathew C. Casimiro, Jie Zhou, Chenguang Wang, Christopher Plymire, Kelly G. Bryant, Kristin M. Daumer, Federica
Sotgia, Gloria Bonuccelli, Agnieszka K. Witkiewicz, Justin Lin, Thai Hong Tran, Janet Milliman, Philippe G. Frank, Jean-François
Jasmin, Hallgeir Rui, Richard G. Pestell, and Michael P. Lisanti
The American Journal of Pathology
(2009)
174 :1172
-
Identification of Gene Expression Signature in Estrogen Receptor Positive Breast Carcinoma
Arvind D. Thakkar, Hemanth Raj, Debarshi Chakrabarti, Ravishankar, N. Saravanan, Bhaskaran Muthuvelan, Arun Balakrishnan,
and Muralidhara Padigaru
Biomarkers in Cancer
(2010)
2 :BIC.S3793
-
HER4 Intracellular Domain (4ICD) Activity in the Developing Mammary Gland and Breast Cancer
Frank E. Jones
Journal of Mammary Gland Biology and Neoplasia
(2008)
13 :247
-
A seven-gene prognostic model for platinum-treated ovarian carcinomas
R Sabatier, P Finetti, J Bonensea, J Jacquemier, J Adelaide, E Lambaudie, P Viens, D Birnbaum, and F Bertucci
British Journal of Cancer
(2011)
105 :304
-
Zinc transporter mRNA expression in the RWPE-1 human prostate epithelial cell line
Amy L. Albrecht, Seema Somji, Mary Ann Sens, Donald A. Sens, and Scott H. Garrett
BioMetals
(2008)
21 :405
-
The Role of Hepsin in Endometrial Carcinoma
Hala S. El-Rebey, Mona A.-H. Kandil, Rehab M. Samaka, Dalia R. Al-Sharaky, and Karim El Deeb
Applied Immunohistochemistry & Molecular Morphology
(2017)
25 :624
-
Targeting RET for thyroid cancer therapy
Cinzia Lanzi, Giuliana Cassinelli, Valentina Nicolini, and Franco Zunino
Biochemical Pharmacology
(2009)
77 :297
-
Breaking the epithelial polarity barrier in cancer: the strange case of LKB1/PAR-4
J. I. Partanen, T. A. Tervonen, and J. Klefstrom
Philosophical Transactions of the Royal Society B: Biological Sciences
(2013)
368 :20130111
-
Estrogen-Mediated Upregulation of Noxa Is Associated with Cell Cycle Progression in Estrogen Receptor-Positive Breast Cancer
Cells
Wensheng Liu, Wendy M. Swetzig, Rajesh Medisetty, Gokul M. Das, and Deodutta Roy
PLoS ONE
(2011)
6 :e29466
-
Fibroblast growth factor receptors, developmental corruption and malignant disease
F. C. Kelleher, H. O'Sullivan, E. Smyth, R. McDermott, and A. Viterbo
Carcinogenesis
(2013)
34 :2198
-
ER and PR signaling nodes during mammary gland development
Tamara Tanos, Lucia Jimenez Rojo, Pablo Echeverria, and Cathrin Brisken
Breast Cancer Research
(2012)
14 :
-
Comprehensive Analysis of the Unfolded Protein Response in Breast Cancer Subtypes
Dadi Jiang, Brandon Turner, Jie Song, Ruijiang Li, Maximilian Diehn, Quynh-Thu Le, Purvesh Khatri, and Albert C. Koong
JCO Precision Oncology
(2017)
:1
-
Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells
Raymond Lo, Lyle Burgoon, Laura MacPherson, Shaimaa Ahmed, and Jason Matthews
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
(2010)
1799 :469
-
Estrogen regulation of X-box binding protein-1 and its role in estrogen induced growth of breast and endometrial cancer cells
Surojeet Sengupta, Catherine G.N. Sharma, and V. Craig Jordan
Hormone Molecular Biology and Clinical Investigation
(2010)
2 :
-
TaqI polymorphism of VDR gene contributes to breast cancer risk
Hua Wang, Wenjian Wang, Dongjie Yang, and Shenming Wang
Tumor Biology
(2014)
35 :93
-
Systemic identification of estrogen-regulated genes in breast cancer cells through cap analysis of gene expression mapping
Ryonosuke Yamaga, Kazuhiro Ikeda, Joost Boele, Kuniko Horie-Inoue, Ken-ichi Takayama, Tomohiko Urano, Kaoru Kaida, Piero Carninci,
Jun Kawai, Yoshihide Hayashizaki, Yasuyoshi Ouchi, Michiel de Hoon, and Satoshi Inoue
Biochemical and Biophysical Research Communications
(2014)
447 :531
-
Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1
(NAT1) as a novel prognostic biomarker
Ida Johansson, Cecilia Nilsson, Pontus Berglund, Martin Lauss, Markus Ringnér, Håkan Olsson, Lena Luts, Edith Sim, Sten Thorstensson,
Marie-Louise Fjällskog, and Ingrid Hedenfalk
Breast Cancer Research
(2012)
14 :
-
Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival
Mikko Pelkonen, Kaisa Luostari, Maria Tengström, Hermanni Ahonen, Bozena Berdel, Vesa Kataja, Ylermi Soini, Veli-Matti Kosma,
and Arto Mannermaa
BMC Cancer
(2015)
15 :
-
Significant gene expression differences in histologically “Normal†liver biopsies: Implications for control tissue
Tarik Asselah, Ivan Bièche, Ingrid Laurendeau, Michelle Martinot-Peignoux, Valerie Paradis, Dominique Vidaud, Dominique-Charles
Valla, Pierre Bedossa, Patrick Marcellin, and Michel Vidaud
Hepatology
(2008)
48 :953
-
Structure–activity relationships and colorimetric properties of specific probes for the putative cancer biomarker human arylamine
N-acetyltransferase 1
James E. Egleton, Cyrille C. Thinnes, Peter T. Seden, Nicola Laurieri, Siu Po Lee, Kate S. Hadavizadeh, Angelina R. Measures,
Alan M. Jones, Sam Thompson, Amy Varney, Graham M. Wynne, Ali Ryan, Edith Sim, and Angela J. Russell
Bioorganic & Medicinal Chemistry
(2014)
22 :3030
-
Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive
breast cancer patients treated with tamoxifen in the advanced setting
Anieta M. Sieuwerts, Maria B. Lyng, Marion E. Meijer-van Gelder, Vanja de Weerd, Fred C.G.J. Sweep, John A. Foekens, Paul
N. Span, John W.M. Martens, and Henrik J. Ditzel
Molecular Oncology
(2014)
8 :1679
-
Estrogen signaling and unfolded protein response in breast cancer
Gayani Rajapaksa, Christoforos Thomas, and Jan-Åke Gustafsson
The Journal of Steroid Biochemistry and Molecular Biology
(2016)
163 :45
-
Investigation of G-quadruplex formation in the FGFR2 promoter region and its transcriptional regulation by liensinine
Lulu Zhang, Wei Tan, Jiang Zhou, Ming Xu, and Gu Yuan
Biochimica et Biophysica Acta (BBA) - General Subjects
(2017)
1861 :884
-
Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone
receptor status with breast cancer risk
Hong Wang, Ziang Yang, and Hongwei Zhang
Breast Cancer Research and Treatment
(2013)
137 :511
-
ArylamineN-acetyltransferase 1 expression in breast cancer cell lines: A potential marker in estrogen receptor-positive tumors
Larissa Wakefield, James Robinson, Hilary Long, J. Claire Ibbitt, Susanna Cooke, Helen C. Hurst, and Edith Sim
Genes, Chromosomes and Cancer
(2008)
47 :118
-
Are trefoil factors oncogenic?
Jo K. Perry, Nagarajan Kannan, Prudence M. Grandison, Murray D. Mitchell, and Peter E. Lobie
Trends in Endocrinology & Metabolism
(2008)
19 :74
-
Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer
Zachary E. Stine, David M. McGaughey, Seneca L. Bessling, Shengchao Li, and Andrew S. McCallion
Human Molecular Genetics
(2011)
20 :3746
-
Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells
Albana Gattelli, Ivan Nalvarte, Anne Boulay, Tim C. Roloff, Martin Schreiber, Neil Carragher, Kenneth K. Macleod, Michaela
Schlederer, Susanne Lienhard, Lukas Kenner, Maria I. Torres-Arzayus, and Nancy E. Hynes
EMBO Molecular Medicine
(2013)
5 :1335
-
NF-κB Signaling Is Required for XBP1 (Unspliced and Spliced)-Mediated Effects on Antiestrogen Responsiveness and Cell Fate
Decisions in Breast Cancer
Rong Hu, Anni Warri, Lu Jin, Alan Zwart, Rebecca B. Riggins, Hong-Bin Fang, and Robert Clarke
Molecular and Cellular Biology
(2015)
35 :379
-
A novel FOXA1/ESR1 interacting pathway: A study of Oncomine™ breast cancer microarrays
Sanjib Chaudhary, B. Madhu Krishna, and Sandip K. Mishra
Oncology Letters
(2017)
14 :1247
-
Novel genes associated with lymph node metastasis in triple negative breast cancer
Andrea Mathe, Michelle Wong-Brown, Brianna Morten, John F. Forbes, Stephen G. Braye, Kelly A. Avery-Kiejda, and Rodney J.
Scott
Scientific Reports
(2015)
5 :
-
Prospective virtual screening with Ultrafast Shape Recognition: the identification of novel inhibitors of arylamine N-acetyltransferases
P. J. Ballester, I. Westwood, N. Laurieri, E. Sim, and W. G. Richards
Journal of The Royal Society Interface
(2010)
7 :335
-
A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
Angelika Brekman, Kathryn E Singh, Alla Polotskaia, Nandini Kundu, and Jill Bargonetti
Breast Cancer Research
(2011)
13 :
-
A candidate molecular signature associated with tamoxifen failure in primary breast cancer
Julie A Vendrell, Katherine E Robertson, Patrice Ravel, Susan E Bray, Agathe Bajard, Colin A Purdie, Catherine Nguyen, Sirwan
M Hadad, Ivan Bieche, Sylvie Chabaud, Thomas Bachelot, Alastair M Thompson, and Pascale A Cohen
Breast Cancer Research
(2008)
10 :
-
Recent Advances in the Role of SLC39A/ZIP Zinc Transporters In Vivo
Teruhisa Takagishi, Takafumi Hara, and Toshiyuki Fukada
International Journal of Molecular Sciences
(2017)
18 :2708
-
Small Molecule Colorimetric Probes for Specific Detection of Human ArylamineN-Acetyltransferase 1, a Potential Breast Cancer
Biomarker
Nicola Laurieri, Matthew H. J. Crawford, Akane Kawamura, Isaac M. Westwood, James Robinson, Ai M. Fletcher, Stephen G. Davies,
Edith Sim, and Angela J. Russell
Journal of the American Chemical Society
(2010)
132 :3238
-
Hydroxysteroid Sulfotransferase SULT2B1b Promotes Hepatocellular Carcinoma Cells Proliferation In Vitro and In Vivo
Xiaoming Yang, Yali Xu, Fenghua Guo, Yanxia Ning, Xiuling Zhi, Lianhua Yin, Xiaobo Li, and Jun Sun
PLoS ONE
(2013)
8 :e60853
-
Cooperating transcription factors mediate the function of estrogen receptor
Elisa Fiorito, Madhumohan R. Katika, and Antoni Hurtado
Chromosoma
(2013)
122 :1
-
Enigma Prevents Cbl-c-Mediated Ubiquitination and Degradation of RETMEN2A
Stephen C. Kales, Marion M. Nau, Anand S. Merchant, Stanley Lipkowitz, and Adriano Marchese
PLoS ONE
(2014)
9 :e87116
-
Neurotrophins and their receptors in breast cancer
Hubert Hondermarck
Cytokine & Growth Factor Reviews
(2012)
23 :357
-
Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis
and is prevalent in triple negative breast cancers
Alison K. Ward, Paul Mellor, Shari E. Smith, Stephanie Kendall, Natasha A. Just, Frederick S. Vizeacoumar, Sabuj Sarker, Zoe
Phillips, Riaz Alvi, Anurag Saxena, Franco J. Vizeacoumar, Svein A. Carlsen, and Deborah H. Anderson
Breast Cancer Research
(2016)
18 :
-
Expression of the RET Proto-oncogene Is Regulated by TFAP2C in Breast Cancer Independent of the Estrogen Receptor
Philip M. Spanheimer, George W. Woodfield, Anthony R. Cyr, Mikhail V. Kulak, Lola S. White-Baer, Thomas B. Bair, and Ronald
J. Weigel
Annals of Surgical Oncology
(2013)
20 :2204
-
Fibroblasts maintained in 3 dimensions show a better differentiation state and higher sensitivity to estrogens
Claudia Montani, Nathalie Steimberg, Jennifer Boniotti, Giorgio Biasiotto, Isabella Zanella, Giuseppe Diafera, Ida Biunno,
Luigi Caimi, Giovanna Mazzoleni, and Diego Di Lorenzo
Toxicology and Applied Pharmacology
(2014)
280 :421
-
Zinc as a Gatekeeper of Immune Function
Nutrients
(2017)
9 :1286
-
Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of
clinical resistance to the aromatase inhibitor, letrozole
William R Miller and Alexey Larionov
Breast Cancer Research
(2010)
12 :
-
Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression
Joel Smith, Martin L. Read, Jon Hoffman, Rachel Brown, Beth Bradshaw, Christopher Campbell, Trevor Cole, Johanna Dieguez Navas,
Fiona Eatock, Justin S. Gundara, Eric Lian, Dom Mcmullan, Neil V. Morgan, Lois Mulligan, Patrick J. Morrison, Mercedes Robledo,
Michael A. Simpson, Vicki E. Smith, Sue Stewart, Richard C. Trembath, Stan Sidhu, Fiona S. Togneri, Naomi C. Wake, Yvonne
Wallis, John C. Watkinson, Eamonn R. Maher, Christopher J. McCabe, and Emma R. Woodward
Human Molecular Genetics
(2016)
25 :1836
-
Interrogating differences in expression of targeted gene sets to predict breast cancer outcome
Sarah A Andres, Guy N Brock, and James L Wittliff
BMC Cancer
(2013)
13 :
-
Cancer outlier detection based on likelihood ratio test
Jianhua Hu
Bioinformatics
(2008)
24 :2193
-
Recent advances on the stimulatory effects of metals in breast cancer
Rosamaria Lappano, Roberta Malaguarnera, Antonino Belfiore, and Marcello Maggiolini
Molecular and Cellular Endocrinology
(2017)
457 :49
-
The Physiological, Biochemical, and Molecular Roles of Zinc Transporters in Zinc Homeostasis and Metabolism
Taiho Kambe, Tokuji Tsuji, Ayako Hashimoto, and Naoya Itsumura
Physiological Reviews
(2015)
95 :749
-
Dysregulated RET Signaling in Thyroid Cancer
Maria Domenica Castellone and Massimo Santoro
Endocrinology and Metabolism Clinics of North America
(2008)
37 :363
-
Polychlorinated biphenyls and breast cancer: A congener-specific meta-analysis
Ling Leng, Jing Li, Xiu-mei Luo, Jun-young Kim, Yi-meng Li, Xue-mei Guo, Xi Chen, Qiao-yun Yang, Guang Li, and Nai-jun Tang
Environment International
(2016)
88 :133
-
A network-based, integrative study to identify core biological pathways that
drive breast cancer clinical subtypes
B Dutta, L Pusztai, Y Qi, F André, V Lazar, G Bianchini, N Ueno, R Agarwal, B Wang, C Y Shiang, G N Hortobagyi, G B Mills,
W F Symmans, and G Balázsi
British Journal of Cancer
(2012)
106 :1107
-
CYP2B6*6 is associated with increased breast cancer risk
Christina Justenhoven, Daniela Pentimalli, Sylvia Rabstein, Volker Harth, Anne Lotz, Beate Pesch, Thomas Brüning, Thilo Dörk,
Peter Schürmann, Natalia Bogdanova, Tjoung-Won Park-Simon, Fergus J. Couch, Janet E. Olson, Peter A. Fasching, Matthias W.
Beckmann, Lothar Häberle, Arif Ekici, Per Hall, Kamilla Czene, Janjun Liu, Jingmei Li, Christian Baisch, Ute Hamann, Yon-Dschun
Ko, and Hiltrud Brauch
International Journal of Cancer
(2014)
134 :426
-
Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples
Timothy R. Wilson, Yuanyuan Xiao, Jill M. Spoerke, Jane Fridlyand, Hartmut Koeppen, Eloisa Fuentes, Ling Y. Huw, Ilma Abbas,
Arjan Gower, Erica B. Schleifman, Rupal Desai, Ling Fu, Teiko Sumiyoshi, Joyce A. O’Shaughnessy, Garret M. Hampton, and Mark
R. Lackner
Breast Cancer Research and Treatment
(2014)
148 :315
-
Brain-derived neurotrophic factor expression predicts adverse pathological & clinical outcomes in human breast cancer
Neill Patani, Wen G Jiang, and Kefah Mokbel
Cancer Cell International
(2011)
11 :23
-
Therapeutic Potentials of BDNF/TrkB in Breast Cancer; Current Status and Perspectives
Amir Tajbakhsh, Amin Mokhtari-Zaer, Mehdi Rezaee, Fahimeh Afzaljavan, Mehdi Rivandi, Seyed Mahdi Hassanian, Gordon A Ferns,
Alireza Pasdar, and Amir Avan
Journal of Cellular Biochemistry
(2017)
118 :2502
-
Investigation of Antitumor Effects of Sorafenib and Lapatinib Alone and in Combination on MCF-7 Breast Cancer Cells
Turgut Kacan, Ahmet Altun, Gulsah Gultekin Altun, Selen Baloglu Kacan, Bulent Sarac, Mehmet Metin Seker, Aykut Bahceci, and
Nalan Babacan
Asian Pacific Journal of Cancer Prevention
(2014)
15 :3185
-
Estrogen Alters the Splicing of Type 1 Corticotropin-Releasing Hormone Receptor in Breast Cancer Cells
S. Lal, A. Allan, D. Markovic, R. Walker, J. Macartney, N. Europe-Finner, A. Tyson-Capper, and D. K. Grammatopoulos
Science Signaling
(2013)
6 :ra53
-
Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its
murine homologue, mouse arylamine N-acetyltransferase 2
Angela J. Russell, Isaac M. Westwood, Matthew H.J. Crawford, James Robinson, Akane Kawamura, Christina Redfield, Nicola Laurieri,
Edward D. Lowe, Stephen G. Davies, and Edith Sim
Bioorganic & Medicinal Chemistry
(2009)
17 :905
-
Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation
C. Hogstrand, P. Kille, R.I. Nicholson, and K.M. Taylor
Trends in Molecular Medicine
(2009)
15 :101
-
Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and
drug resistance
Rodney F. Minchin and Neville J. Butcher
BMC Genomics
(2018)
19 :
-
Crosstalk Between theFGFR2andTP53Genes in Breast Cancer: Data from an Association Study and Epistatic Interaction Analysis
Nadezhda V. Cherdyntseva, Evgeny V. Denisov, Nicolay V. Litviakov, Vladimir N. Maksimov, Elena A. Malinovskaya, Natalia N.
Babyshkina, Elena M. Slonimskaya, Mikhail I. Voevoda, and Evgeny L. Choinzonov
DNA and Cell Biology
(2012)
31 :306
-
Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer
Marie-Emmanuelle Legrier, Ivan Bièche, Julie Gaston, Arnaud Beurdeley, Vanessa Yvonnet, Olivier Déas, Aurélie Thuleau, Sophie
Château-Joubert, Jean-Luc Servely, Sophie Vacher, Myriam Lassalle, Stéphane Depil, Gordon C Tucker, Jean-Jacques Fontaine,
Marie-France Poupon, Sergio Roman-Roman, Jean-Gabriel Judde, Didier Decaudin, Stefano Cairo, and Elisabetta Marangoni
British Journal of Cancer
(2016)
114 :177
-
Chromatin context dominates estrogen regulation of pS2 gene expression
Akua K. Oduro, Michael K. Fritsch, and Fern E. Murdoch
Experimental Cell Research
(2008)
314 :2796
-
Mammalian Zinc Transporters: Nutritional and Physiologic Regulation
Louis A. Lichten and Robert J. Cousins
Annual Review of Nutrition
(2009)
29 :153
-
Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells
Robert Clarke, Ayesha N. Shajahan, Rebecca B. Riggins, Younsook Cho, Anatasha Crawford, Jianhua Xuan, Yue Wang, Alan Zwart,
Ruchi Nehra, and Minetta C. Liu
The Journal of Steroid Biochemistry and Molecular Biology
(2009)
114 :8
-
Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine
stimulus involving FGF10
Petra EA Huijts, Minka van Dongen, Moniek CM de Goeij, Adrian J van Moolenbroek, Freek Blanken, Maaike PG Vreeswijk, Esther
M de Kruijf, Wilma E Mesker, Erik W van Zwet, Rob AEM Tollenaar, Vincent THBM Smit, Christi J van Asperen, and Peter Devilee
Breast Cancer Research
(2011)
13 :
-
Overexpression of SULT2B1b is an independent prognostic indicator and promotes cell growth and invasion in colorectal carcinoma
Liang Hu, Guang-Zhen Yang, Yu Zhang, Dan Feng, Yan-Xia Zhai, Hui Gong, Chen-Ye Qi, Hao Fu, Ming-Ming Ye, Qing-Ping Cai, and
Chun-Fang Gao
Laboratory Investigation
(2015)
95 :1005
-
Determining and Interpreting New Predictive Rules for Breast Cancer Familial Inheritance
Stefania Tommasi, Giuseppina Iannelli, Filippo Menolascina, Vita Fedele, Vitoantonio Bevilacqua, and Angelo Paradiso
OMICS: A Journal of Integrative Biology
(2011)
15 :125
-
Reciprocal feedback regulation of ST3GAL1 and GFRA1 signaling in breast cancer cells
Tan-chi Fan, Hui Ling Yeo, Huan-Ming Hsu, Jyh-Cherng Yu, Ming-Yi Ho, Wen-Der Lin, Nai-Chuan Chang, John Yu, and Alice L. Yu
Cancer Letters
(2018)
434 :184
-
Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and
Caucasian-American Women diagnosed with breast cancer
Jessica M Grunda, Adam D Steg, Qinghua He, Mark R Steciuk, Suzanne Byan-Parker, Martin R Johnson, and William E Grizzle
BMC Research Notes
(2012)
5 :248
-
Zinc and its transporter ZIP6 are key mediators of breast cancer cell survival under high glucose conditions
Chihiro Matsui, Tomoka Takatani-Nakase, Yuki Hatano, Satomi Kawahara, Ikuhiko Nakase, and Koichi Takahashi
FEBS Letters
(2017)
591 :3348
-
Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women
J. Liang, P. Chen, Z. Hu, X. Zhou, L. Chen, M. Li, Y. Wang, J. Tang, H. Wang, and H. Shen
Carcinogenesis
(2008)
29 :2341
-
Protein tyrosine phosphatases as novel targets in breast cancer therapy
Caroline E. Nunes-Xavier, Jorge Martín-Pérez, Ari Elson, and Rafael Pulido
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
(2013)
1836 :211
-
Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents
Jonathan McConathy, Weiping Yu, Nachwa Jarkas, Wonewoo Seo, David M. Schuster, and Mark M. Goodman
Medicinal Research Reviews
(2012)
32 :868
-
New Potential Biomarker Proteins for Alcoholic Liver Disease Identified by a Comparative Proteomics Approach
Su Jin Lee, Da Eun Lee, Jeong Han Kang, Min-Jeong Nam, Jeen-Woo Park, Beom Sik Kang, Dong-Seok Lee, Hyun-Shik Lee, and Oh-Shin
Kwon
Journal of Cellular Biochemistry
(2017)
118 :1189
-
Activation function 2 mediates dioxin-induced recruitment of estrogen receptor alpha to CYP1A1 and CYP1B1
Laura MacPherson, Raymond Lo, Shaimaa Ahmed, Andrea Pansoy, and Jason Matthews
Biochemical and Biophysical Research Communications
(2009)
385 :263
-
Epidermal Growth Factor Receptor (EGFR)-mediated Positive Feedback of Protein-tyrosine Phosphatase ϵ (PTPϵ) on ERK1/2 and
AKT Protein Pathways Is Required for Survival of Human Breast Cancer Cells
Caroline E. Nunes-Xavier, Ari Elson, and Rafael Pulido
Journal of Biological Chemistry
(2012)
287 :3433
-
Distinct Pathways Regulated by RET and Estrogen Receptor in Luminal Breast Cancer Demonstrate the Biological Basis for Combination
Therapy
Philip M. Spanheimer, Anthony R. Cyr, Matthew P. Gillum, George W. Woodfield, Ryan W. Askeland, and Ronald J. Weigel
Annals of Surgery
(2014)
259 :793
-
A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection
of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow
Kjersti Tjensvoll, Bjørnar Gilje, Satu Oltedal, Victor F. Shammas, Jan Terje Kvaløy, Reino Heikkilä, and Oddmund Nordgård
Breast Cancer Research and Treatment
(2009)
116 :329
-
RET: A Multi-Faceted Gene in Human Cancer
Massimo Santoro, Francesca Carlomagno, and Rosa Marina Melillo
Endocrinology and Metabolism
(2012)
27 :173
